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Purpose: To identify the gene mutation underlying Avellino corneal dystrophy in a four-generation Chinese pedigree.
Methods: Patients from the affected family underwent detailed clinical examination involving slit-lamp photography and
confocal microscopy. Genomic DNA extracted from peripheral leukocytes was amplified using touch-down PCR for gene
scanning. Two-point linkage analysis and haplotyping were performed to map the relevant chromosome region. The
candidate gene in this region was sequenced to screen out the disease-causing mutation.
Results: Patients in the pedigree were diagnosed with Avellino corneal dystrophy. Using linkage analysis, the responsible
gene was mapped to chromosome 5q31.2 with a maximum LOD (log odds) score (Zmax) of 3.23 at D5S479 (θmax=0.0).
Haplotypes constructed from 11 microstallite markers identified the disease-linked chromosome region as being below
D5S808. Sequencing of TGFBI (transforming growth factor-beta induced gene), a known gene in this region, revealed a
heterozygous transition (c.418 G>A) in exon 4 resulting in Arg124His (R124H) being co-segregated with the disease in
affected family members but not in the unaffected members or the 50 unrelated controls.
Conclusions: Our study demonstrated that a G>A transition in Arg124His of TGFBI was responsible for Avellino corneal
dystrophy in a Chinese pedigree. This result further supports the importance of TGFBIp in maintaining transparency of
the cornea.
Corneal dystrophy is a heterogeneous inherited disease
with  bilateral,  symmetric,  non-inflammatory,  progressive
cornea  opacities  which  lead  to  varying  degrees  of  visual
impairment.  Clinical  examination  using  slit-lamp
photography, confocal microscopy and histological staining,
enable corneal dystrophies to be categorized as epithelial, sub-
epithelial,  Bowman’s  layer,  stromal,  and  endothelial
according to the affected layer in the cornea. More than twenty
types of corneal dystrophy have so far been categorized based
on  disease  features  including  physical  appearance,  age  of
onset  and  histological  tests  [1].  Historically,  clinical
classification of corneal dystrophy has been based entirely on
ophthalmological and histopathologic examination but these
have proved to be limited in scope and effectiveness [2].
More recently the development of molecular genetics has
enabled isolated corneal dystrophy to be linked to autosomal
dominant,  autosomal  recessive  or  X-linked  recessive
Mandelian  inheritance  traits  even  where  penetrance  is
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variable.  Most  of  the  genes  responsible  for  corneal
dystrophies can be identified by pedigree analysis including
linkage analysis, haplotyping and direct sequencing based on
the  particular  corneal  dystrophy  affecting  the  group.
Individual mutations related to a particular disorder have often
been reported in families of varying origins. Genetic studies
have  identified  eleven  chromosomes  related  to  corneal
dystrophy: 1, 2, 5, 9, 10, 12, 13, 16, 17, 20, and X. Several
genes in regions responsible for corneal dystrophy have also
been identified, including the transforming growth factor-
beta-induced  gene  (TGFBI),  the  carbohydrate
sulfotransferase 6 gene (CHST6), the gelsolin gene (GSN), the
keratin 3 gene (KRT3), the keratin 12 gene (KRT12) and the
surface marker 1 gene (M1S1) [1,3].
Increasing genetic knowledge, as well as revealing the
molecular basis of corneal dystrophy has also raised questions
relating to phenotypic and genetic heterogeneity aspects of the
disease. Studies have revealed that different phenotypes of
corneal dystrophy share a common gene or mutation in the
same site, or even the same mutation. The most powerful
evidence has come from TGFBI-related corneal dystrophies.
Different types of corneal dystrophy have been categorized
including  granular  corneal  dystrophy  (GCD)  and  lattice
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3200corneal dystrophy (LCD) [4]. As a special critical mutation,
Arg124His of TGFBI corresponds to several subtypes of GCD
and LCD in families of different ethnic origin while different
mutations in the same genes or even the same mutation can
result  in  a  single  phenotype.  For  example,  two  distinct
mutations Arg124Ser and Arg555Trp have been found to
cause the common subtype of GCD, namely granular corneal
dystrophy type I (GCD1) [4]. The complexity of phenotypic
and  genetic  heterogeneity  therefore  complicates  the
identification of the causes of the disease.
The challenge to ophthalmologists and researchers is to
correctly diagnose and classify corneal dystrophies, as well as
to understand their phenotype-genotype aspects. In 2008, a
useful nomenclature for corneal dystrophies was established
by  the  International  Committee  on  the  Classification  of
Corneal  dystrophies  (IC3D)  based  on  traditional  clinical
examination and advances in molecular genetics. Under the
IC3D classification system, each dystrophy has a detailed
description including an OMIM number, eponyms, genetic
loci, relevant genes, onset, signs, symptoms, histopathology,
etc., combining clinical features and genetic characteristics
including molecular mechanism and protein functions [5-7].
In  this  study,  we  recruited  a  Chinese  four-generation
pedigree affected by corneal dystrophy and identified the gene
mutation responsible for the disease. We hope our study will
provide an insight into the mechanisms of the disease.
METHODS
Clinical examinations: This research was approved by the
ethics committee of Shanghai Xinhua Hospital in Shanghai,
China. Twenty-three members in a four-generation Chinese
pedigree  in  Han  population  with  corneal  dystrophy  were
recruited  for  the  study.  Informed  consent  was  signed  in
accordance with the Helsinki Declaration by all participants.
Full  family  medical  history  was  recorded.  Participating
members  underwent  careful  ophthalmic  examination
including  visual  acuity  tests,  slit-lamp  examination  and
confocal microscopy (Heidelberg retinal tomography; HRT-
II, Heidelberg, Germany). Fifty unrelated subjects without
corneal dystrophy were recruited from the Ophthalmology
Clinic of Xinhua Hospital as normal controls for the study.
Genescan and genotyping: Genomic DNA was extracted from
peripheral leukocytes using the QIAamp Blood Mini DNA kit
(Qiagen,  Santa  Clara,  CA).  Genescanning  was  performed
using  microsatellite  markers  based  on  the  NCBI  span  of
known  genes  related  to  granular  corneal  dystrophy.
Genotyping was performed using capillary electrophorese of
the touchdown PCR mixture.
A three-temperature touchdown PCR program was used
for DNA amplifying: 96 °C for 12 min; 14 cycles at 95 °C for
30 s, 64 °C for 30 s (with temperature decreasing from 64 °C
to 57 °C by −0.5 per cycle), 72 °C for 30 s; additional 30 cycles
at 95 °C for 30 s, 57 °C for 30 s, 72 °C for 30 s; and a final
extension at 72 °C for 10 min, using the Gene Amp PCR
System 9700 (PE Applied Biosystems, Foster City, CA).
Standard PCR reactions wes preformed in a 5 μl volume
containing 20 ng template DNA, 0.1 μM of each primer,
300 μM dNTP, 1 µl of 10× PCR buffer, 7 mM MgCl2, and 0.3
U Hotstart Taq.
The  PCR  products  were  mixed  according  to  size
(Genescan-400HD ROX; Perkin Elmer, Foster City, CA),
denatured at 95 °C for 1 min and electrophoresed on a 96-
capillary  automated  DNA  sequencer  (MegaBACE  1000;
Amersham,  Freiburg,  Germany).  Genotyping  data  were
analyzed  on  Genetic  Profiler  software  (version  1.5,
Amersham).
Linkage  analysis  and  haplotyping:  Genotyping  data  were
calculated  using  the  MLINK  subprogram  from  the
LINKAGE  package  (version  5.1)  for  two-point  linkage
analysis.  Microsatellite  markers,  allele  frequencies  and
recombination distances between the marker loci were based
on  the  Marshfield  Database  and  the  UCSC  Database.
Autosomal dominant inheritance, disease-gene frequency of
0.0001 and full penetrance were assumed. Cyrillic (version
2.1) software was used for haplotype construction.
Mutation sequencing: TGFBI, the relevant gene for corneal
dystrophy in the defined region was sequenced to screen the
mutation  in  coding  exons,  splice  regions  and  UTRs.
Sequencing  reactions  were  performed  using  the  BigDye
Terminator Cycle Sequencing Kit v3.1 (Applied Biosystems,
Foster City, CA) on an ABI PRISMTM 3730xl analyzer.
Sequencing data were analyzed using Sequence Scanner v1.0
software referencing the NCBI GeneBank (NM_000358 for
TGFBI). Gene mutation was confirmed in all family subjects
and unrelated controls.
RESULTS
Clinical features: The twenty-three members (six affected and
seventeen unaffected individuals) participating in the study
were recruited from a four-generation Chinese pedigree that
consist  of  forty-two  individuals  including  the  six  patients
(Figure 1). Affected individuals in the family were having
low myopia decreased vision of both eyes but had no other
ocular  abnormalities.  Their  best  corrected  visual  acuity
(BCVA)  was  20/60–20/30.  Even  intraocular  pressure  was
normal  with  18.4±2.3  mmHg  on  the  right  eye  and
17.6±1.8 mmHg on the left eye, which indicated that corneal
dystrophy  in  the  family  didn’t  result  in  corneal  edema.
Proband (II:4) and her siblings (II:1, II:8, and II:12) had only
slow vision decrease but had no other ocular problems when
growing up and had been diagnosed with corneal dystrophy
after  the  age  of  48.  Two  of  those  affected  in  the  next
generation, the nieces (III:13 and III:15) of the proband, had
had obvious visual impairment as well as symptoms of gradual
photophobia,  lacrimation,  dry  eye,  and  foreign-body
sensation  by  the  age  of  30  and  25,  respectively.  Further
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3201ophthalmic  examination  showed  that  they  had
recurrent corneal epithelial erosion which was susceptible to
relief  with  anti-inflammatory  treatment,  cornea  re-
epithelialization, and the use of artificial tears.
Slit  lamp  examination  showed  a  gray  white  deposit
located beneath the central cornea, involving the Bowman
layer  and  superficial  stroma.  Opacities  initially  appeared
granular,  snow-flake,  star  or  branch  shaped  but  gradually
coalesced to form a circle or irregular block (Figure 2). Visual
impairment of Individual II:1, the elder brother of the proband
was less than that of the proband (II:4) and her sisters (II:8
and II:12). Corneal dystrophies in individuals III:13 and III:
15 were worse than in the older generation and exhibited
punctate  corneal  epithelial  shedding.  Numerous  hyper-
reflective  dots  with  sharp  shapes  were  scattered  in  the
superficial corneal stroma, mostly between stromal cells and
nerve fibers. Their diameter covered dozens of stromal cells
(Figure 2). Affected individuals in the family were diagnosed
as  having  granular  corneal  dystrophy  type  II  (GCD  2)  –
Avellino corneal dystrophy.
Linkage and haplotype analysis: Indicative results were first
observed  on  chromosome  5  in  the  screening  of  granular
corneal dystrophy related loci. Several markers were then
selected for further study, and positive LOD (log odds) scores
were obtained, including the maximum LOD score (Zmax) of
3.23 at D5S479 (θmax=0.00; Table 1). Haplotyping revealed
three  informative  recombination  events  occurring  in  the
family.  Crossover  occurred  in  II:15  suggesting  that  the
proximal border was between D5S471 and D5S804. The other
two recombinations occurred in individuals II:8 and III:13
where the proximal border was narrower at between D5S808
and D5S2115. We therefore concluded that the chromosome
region responsible for corneal dystrophy in this family is
below D5S808.
Mutation  analysis:  The  gene  TGFBI  (bp:  135,364,584–
135,399,507) which is known to be related to granular corneal
dystrophy,  is  exactly  below  D5S808  (bp:  133,533,511–
133,733,691) and was sequenced first. Direct sequencing of
the UTRs, exons, and exon/intron boundaries were performed
in affected and unaffected family members and 50 normal
controls (sequencing primers are presented in Table 2). A
heterozygous c.418 G>A mutation in exon 4 of TGFBI was
identified in all affected individuals but not in unaffected
members or controls. This mutation led to a substitution at
codon  124  (Arg124His,  R124H)  which  is  responsible  for
Avellino corneal dystrophy in this family (Figure 3).
DISCUSSION
As the most common type of corneal dystrophy, granular
corneal dystrophy involves the anterior corneal stroma and
can  be  divided  into  three  subtypes.  Granular  corneal
dystrophy  type  I  (GCD1,  OMIM  121900),  also  know  as
classic granular corneal dystrophy, presents ‘bread-crumb-
like’ white well defined granular opacities within a crystal
clear cornea and onset is usually in the first decade of life. The
onset of Granular corneal dystrophy type II (GCD2, OMIM
607541), also known as Avellino corneal dystrophy (ACD),
often occurs in the second decade and demonstrates fewer
Figure 1. Pedigree and haplotyping of the family with Avellino corneal dystrophy. Squares and circles indicate males and females, respectively;
affected individuals are shaded black; An arrow denotes the proband. Black and white bars depict the disease and non-disease associated
haplotypes respectively. Haplotyping with STR markers harbored the causative gene located below D5S808.
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clear superficial mid stroma and lattice lines sometimes in
deeper corneas. Visual acuity in GCD2 is less impaired than
in GCD1 because of the slower progression of the disease.
Granular corneal dystrophy type III (GCD3, OMIM 608470),
also  called  Reis-Bücklers  corneal  dystrophy  (RBCD),  has
been  found  to  exhibit  opacities  in  irregularly  ring-shaped
spots and lines in the superficial cornea. In the present genetic
study, we recruited a four-generation Chinese pedigree having
corneal  dystrophy.  Slit-lamp  photography  and  confocal
microscopy  examination  showed  affected  members  in  the
family to have granular corneal dystrophy type II, namely
Avellino corneal dystrophy. The disease gene was mapped to
5q31, the exact location of TGFBI. Direct sequencing then
revealed that the c.418 G>A mutation of TGFBI resulting in
Arg124His was responsible for Avellino corneal dystrophy in
the pedigree. Our result further supports the importance of
TGFBIp in maintaining corneal transparency.
TGFBI,  the  transforming  growth  factor-beta  induced
gene (also known as BIGH3, OMIM 601692), was initially
observed  to  be  inducibly  expressed  in  the  human  lung
adenocarcinoma cell line A549 and in several other cell lines
in 1992 [8]. Two years later, TGFBI protein (TGFBIp) was
found expressed in the cornea [9] and its chromosome locus
found to be involved in corneal dystrophy [10]. In 1997,
Munier et al. [11] first reported that TGFBI mutations were
related to corneal dystrophy. TGFBI comprises 17 exons and
encodes  a  68  kDa  extracellular  matrix  protein  (TGFBIp,
Figure  2.  Slit-lamp  photographs
showing granular deposits distributed in
the  left  eye  (A,  individual  III:13;  B,
individual III:15). The arrow indicates
liner opacities in the superficial stroma.
Confocal  images  showing  numerous
hyper-reflective dots with sharp shapes
scattered  between  stromal  cells  and
nerve fibers in the superficial corneal
stroma in the left (C) and right eye (D)
both of individual III:13.
TABLE 1. TWO POINT LOD SCORES FOR AUTOSOMAL DOMINANT AVELLINO CORNEAL DYSTROPHY ON CHROMOSOME 5P.
    LOD score at θ=    
Marker Mb 0.0 0.1 0.2 0.3 0.4 Zmax θmax
D5S2027 111,045,419–111,245,714 −4.44 −0.83 −0.35 −0.11 −0.01 −0.01 0.4
D5S471 118,948,944–119,149,278 −3.62 −0.41 −0.22 −0.14 −0.07 −0.07 0.4
D5S804 124,984,914–125,185,374 −2.95 1.18 0.99 0.61 0.19 1.18 0.1
D5S2053 133,016,815–133,217,150 1.46 1.24 0.99 0.71 0.38 1.46 0.0
D5S1995 133,219,912–133,420,267 0.27 0.23 0.18 0.13 0.07 0.27 0.0
D5S808 133,533,511–133,733,691 −2.90 1.34 1.14 0.76 0.30 1.34 0.1
D5S2115 134,619,248–134,819,548 2.93 2.39 1.79 1.11 0.38 2.93 0.0
D5S816 135,201,390–135,401,753 1.44 1.21 0.97 0.69 0.37 1.44 0.0
D5S479 136,205,608–136,405,941 3.23 2.70 2.09 1.41 0.65 3.23 0.0
D5S436 145,103,918–145,304,281 0.57 0.49 0.39 0.27 0.15 0.57 0.0
D5S410 152,674,975–152,875,361 1.59 1.28 0.94 0.56 0.19 1.59 0.0
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3203kerato-epithelin, KE) which is expressed in the cornea, skin,
bone, tendon, kidney and other connective tissues. TGFBIp
comprises 683 amino acids and contains an N-teminal signal
peptide  (Met1-Ala23),  four  internal  homologous  repeat
domains and a highly conserved COOH-terminal sequence
that  is  the  integrin-binding  motif  RGD  (Arg642-Gly643-
Asp644). The NH2-terminal sequence contains a cysteine-rich
EMI domain (Gly45-Ala99) which was initially recognized in
EMILINs [12]. Residue Ala100-Pro635 is composed of four
fasciclin (FAS) domains consisting of 140 amino acids each
fasc1–4. FAS-containing proteins play an important role in
extracellular  or  membrane  binding  in  cell  adhesion.  Two
conserved sequences, Asn-Lys-Asp-Ile-Leu within fasc 2 and
Glu-Pro-Asp-Ile-Met within fasc 4 have been identified as
mediating cell adhesion. Studies have shown that not all four
domains (fasc1–4) are equally important in mediating the
normal  activity  of  TGFBIp.  Fasc1  and  fasc  4  play  more
important roles than other two fasc domains, though their
specific  interaction  with  other  unknown  proteins  is  still
unclear  [13,14].  COOH-terminally  processed  and  matured
corneal TGFBIp isoform. RGD is known to act as a ligand
recognition sequence for integrins in modulating cell adhesion
within the extracellular matrix (ECM). Ser658-His683 in the
C-terminal is critical for function malignance of RGD because
the lack of these residues is liable to expose the RGD sequence
to  interactions  [15,16].  TGFBIp  widely  expresses  in  the
extracellular matrix of many organs and interacts with other
matrix proteins, such as fibronectin, different integrins, and
collagens [17-19].
Numerous  studies  have  indicated  that  TGFBI  is  the
important  disease  gene  underlying  corneal  dystrophy.
Mutations of TGFBI mainly occur in exon 4, 11, 12, and 14.
Up to now, more than 50 mutations in TGFBI have been
proved to be associated with corneal dystrophy, including
epithelial basement membrane corneal dystrophy (EBMD,
OMIM 121820), Bowman’s layer dystrophies: Thiel-Behnke
corneal dystrophy (TBCD, OMIM 602082), Reis-Bücklers
corneal dystrophy, and the stromal dystrophies: lattice corneal
dystrophy type I (LCD I, OMIM 122200), GCD1, and GCD2.
Mutations occur in two arginine codons, Arg124 and
Arg555,  which  account  for  more  than  half  of  TGFBI
mutations in corneal dystrophy, indicating that these two sites
are mutant hotspots of TGFBI. Studies suggest that these two
mutations are likely to affect protein–protein interactions in
TGFBI-mediated  cell-adhesion.  Arg124,  along  with  two
valines  at  positions  112–113,  as  well  as  disulfide  and
hydrogen bonding, is the most important factor for amyloid
formation of TGFBIp [20]. Four different mutations in this
position have been linked with corneal dystrophies in families
worldwide [21]: transition c.417 C>T leading to Arg124Cys
(R124C) has been identified in GCD2 [22] and LCD1 [23,
24]; transversion c.417 C>A resulting in Arg124Ser (R124S)
has been found to be related to a phenotypic variant of GCD1
[25]; transition c.418 G>A is known to cause Arg124His
(R124H) in GCD2, or a mixed type of amyloid and granular
deposits  [26];  while  transversion  c.418  G>T  resulting  in
Arg124Leu  (R124L)  has  been  reported  in  GCD3,  a
phenotypic  variant  of  GCD1  characterized  by  superﬁcial
granular deposits [27,28]. Nucleotides CGG (c.1710–1712) in
exon 12 encode amino acid Arg555 in the fasc-4 domain.
Transition c.1710 C>T resulting in Arg555Trp (R555W) is
associated with GCD1 [26] or the phenotype similar to GCD1
and transition c.1712 G>A resulting in Arg555Gln (R555Q)
is responsible for Thiel-Behnke corneal dystrophy [29,30].
TABLE 2. PRIMERS DESIGNED FOR SEQUENCING OF THE TGFBI GENE.
Primer for exon Forward Reverse Length (bp)
1 caggaggcctaagggaccta ctccatgctgcaaggttttt 607
2 tcaattgcccatgtcaaaga gccctgaaaaatgtctccaa 607
3 ccagttggttggctgtaggt gaggagcagctcaggaaatg 514
4 ccccagaggccatccctcct ccgggcagacggaggtcatc 358
5 ggcatgatgaatgggagtct gagaagcaggcacaaagagg 579
6 tctccttgggccctctatt tcaggggaacctgctctatg 416
7 aggaagaggaaaggcaggtt agcaacaggacaggatgacc 532
8 agaaggcgaggaggatctg gtcacaacccacacatttgc 527
9 tgactgttcccctgatgaca ttttggttgagctgagtgga 434
10 ttggcagcttcacttggttt ttccttccttgtcagcaacc 409
11 tcccagccttaataacccatc cttttccccatcccaagtct 433
12 tccagtggcctggactctac gatgtgccaactgtttgctg 337
13 tgctttgtgtcctctgacca catcctgggggtgagatatg 402
14 ggcgacaagattgaaactcc cccaattcactctgcaatca 405
15 tgtgcattcacctttcttgg agtgggagtggggagaagtt 406
16 gtccacctgaaggcacactt ccaagtcaccctgctgttct 393
17 cacctgctatgtgcaggaga ggctggattgcttgattcat 532
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3204TGFBIp  is  known  to  bind  collagen  microfibrils  with
covalent and mediates the adhesion of various cell types. In
the  cornea,  TGFBIp  is  preferentially  expressed  on  the
extracellular surface of corneal epithelial cells [31]. EMI,
fasc1–4 and RGD are critical for TGFBIp in cell-collagen
interactions with a role in the regulation of cell-adhesion in
maintenance  of  tissue  architecture.  Fasc1  is  important  in
mediating the normal activity of TGFBIp for FAS-containing
proteins play an important role in extracellular or membrane
binding in cell adhesion. We consider that change of Arg124
in fasc1 may effect on the structure formation or functional
performing  of  TGFBIp,which  indicated  Arg124  is  a
conserved amino acid for TGFBIp. It is interesting that though
TGFBIp expresses in many organ, such as skin, bone, kidney
and so on, manifestations of its mutation have been found only
in the cornea [32]. How mutations of TGFBI cause corneal
dystrophy  is  still  unknown.  Researches  including  gene
functional study are needed for further confirmation. Factors
Figure  3.  Sequence  analysis  of  the
Chinese pedigree with Avellino corneal
dystrophy.  Position  c.418  G>A
transition  (indicated  by  the  arrow)
resulting  in  Arg124His  (R124H)  co-
segrated with all patients in the family,
but  was  not  found  in  the  unaffected
family members nor in the 50 unrelated
control subjects.
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3205such as age, environment, and modifier genes may influence
the expressivity and penetrance of corneal dystrophy. Despite
of this, genetic studies of corneal dystrophy are still not only
useful for ophthalmologist in clinical diagnosis, but can also
help future research into the molecular mechanism underlying
the disease.
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